Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3444-3450

  Bastiani, Lisa ^a   Laal, Suman ^a,b   Kim, Mimi ^a   Zolla Pazner, Susan ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ADHESION; CELL TYPE; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

EID: 0030945243     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3444-3450.1997     Document Type: Article

References (49)

1. Arthur, L. O., J. W. Bess, Jr., R. C. Sowder II, R. E. Benveniste, D. L. Mann, J. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
2. Atkin, A., G. Pestano, D. Serwadda, A. M. Prince, D. Pascual, N. Sewankambo, and W. M. O. Boto. 1993. Phylogenetic and serological characterization of two Ugandan HIV-1 isolates. AIDS Res. Hum. Retroviruses 9:351-356.
3. Azocar, J., and M. Essex. 1979. Incorporation of HLA antigens into the envelope of RNA tumor viruses grown in human cells. Cancer Res. 39:3388-3391.
4. Bowen, M. A., D. D. Patel, X. Li, B. Modrell, A. R. Malacko, W. Wang, H. Marquardt, M. Neubauer, J. M. Pesando, U. Francke, B. F. Haynes, and A. Aruffo. 1995. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med. 181:2213-2220.
5. Bradac, J. Personal communication.
6. Bubbers, J. E., and F. Lilly. 1977. Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature 266:458-459.
7. Butini, L., A. R. De Fougerolles, M. Vaccarezza, C. Graziosi, D. I. Cohen, M. Montroni, T. A. Springer, G. Pantaleo, and A. S. Fauci. 1994. Intercellular adhesion molecules (ICAM)-1 ICAM-2 and ICAM-3 function as counter-receptors for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation. Eur. J. Immunol. 24:2191-2195.
8. Callahan, L. 1994. HIV-1 virion-cell interactions: an electrostatic model of pathogenicity and syncytium formation. AIDS Res. Hum. Retroviruses 10: 231-233.
9. Cantin, R., J.-F. Fortin, and M. Tremblay. 1996. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology 218:372-381.
10. Capobianchi, M. R., S. Fais, C. Castilletti, M. Gentile, F. Ameglio, and F. Dianzani. 1994. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J. Infect. Dis. 169:886-889.
11. Castilletti, C., M. R. Capobianchi, S. Fais, I. Abbate, B. Ficociello, F. Ameglio, P. Cordiali Fei, S. M. Santini, and F. Dianzani. 1995. HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res. Hum. Retroviruses 11:547-553.
12. de Thé, G., C. Becker, and J. W. Beard. 1964. Virus of avian myeloblastosis (BAI strain A). XXV. Ultracytochemical study of virus and myeloblast phosphatase activity. J. Natl. Cancer Inst. 32:201-235.
13. Dusing, S., and M. Stefanski. Personal communication.
14. Foley, G. E., H. Lazarus, S. Farber, B. G. Uzman, B. A. Boone, and R. E. McCarthy. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522-529.
15. Frank, I., H. Stoiber, S. Godar, H. Stockinger, F. Steindl, H. W. D. Katinger, and M. P. Dierich. 1996. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS 10:1611-1620.
16. Franke, E. K., H. E. H. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
17. Gomez, M. P., and J. E. K. Hildreth. 1995. Antibody to adhesion molecule LFA-1 enhances AIDS plasma neutralization of HIV-1. J. Virol. 69:4628-4632.
18. Gorny, M. K., V. Gianakakos, S. Sharpe, and S. Zolla-Pazner. 1989. Generation of human monoclonal antibodies to human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:1624-1628.
19. Guo, M. M. L., and J. E. K. Hildreth. 1993. HIV-induced loss of CD44 expression in monocytic cell lines. J. Immunol. 151:2225-2236.
20. Guo, M. M. L., and J. E. K. Hildreth. 1995. HIV acquires functional adhesion receptors from host cells. AIDS Res. Hum. Retroviruses 11:1007-1013.
21. Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563-566.
22. Hildreth, J. E. K., and R. J. Orentas. 1989. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244:1075-1078.
23. Hioe, C., J. E. K. Hildreth, B. F. Haynes, and S. Zolla-Pazner. 1996. Antibodies to adhesion molecules and V3 act in synergy to neutralize HIV-1 primary isolates, abstr. 94, p. 70. In 3rd Conference on Retroviruses and Opportunistic Infections.
24. Hoxie, J. A., T. P. Fitzharris, P. R. Youngbar, D. M. Matthews, J. L. Rackowski, and S. F. Radka. 1987. Nonrandom association of cellular antigens with HTLV-III virions. Hum. Immunol. 18:39-52.
25. Kerkau, R., R. Schmitt-Landgraf, A. Schimpl, and E. Wecker. 1989. Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res. Hum. Retroviruses 5:613-620.
26. Korber, B. M., K. MacInnes, R. F. Smith, and G. Myers. 1994. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J. Virol. 68:6730-6744.
27. Lando, Z., P. Sarin, M. Megson, W. C. Greene, T. A. Waldman, R. C. Gallo, and S. Broder. 1983. Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T cell growth factor receptor. Nature 305:733-736.
28. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695-714.
29. Mascola, J. R., J. Louwagie, F. E. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A. K. Fowler, J. G. McNeil, and D. S. Burke. 1994. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
30. Michelson, S., P. Turowski, L. Picard, J. Goris, M. P. Landini, A. Topilko, B. Hemmings, C. Bessia, A. Garcia, and J. L. Virelizier. 1996. Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-celf derived PP2A. J. Virol. 70:1415-1423.
31. Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas III, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
32. Nara, P. L., W. C. Hatch, N. M. Dunlop, W. G. Robey, L. O. Arthur, M. A. Gonda, and P. J. Fischinger. 1987. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses 3:283-302.
33. Noraz, N., B. Verrier, C. Fraisier, and C. Desgranges. 1995. Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type I or coinfectcd with the two viruses. AIDS Res. Hum. Retroviruses 11:145-154.
34. Orentas, R. J., and J. E. K. Hildreth. 1993. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses 9:1157-1165.
35. Ott, D. E., L. V. Coren, D. G. Johnson, R. C. Sowder II, L. O. Arthur, and L. E. Henderson. 1995. Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res. Hum. Retroviruses 11:1003-1006.
36. Saifuddin, M., C. J. Parker, M. E. Peeples, M. K. Gorny, S. Zolla-Pazner, M. Ghassemi, I. A. Rooney, J. P. Atkinson, and G. T. Spear. 1995. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J. Exp. Med. 182:501-509.
37. Sawyer, L. S. W., M. T. Wrin, L. Crawford-Miksza, B. Potts, Y. Wu, P. A. Weber, R. D. Alfonso, and C. V. Hanson. 1994. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68:1342-1349.
38. Smith, S. D., M. Shatsky, P. S. Cohen, R. Warnke, M. P. Link, and B. E. Glader. 1984. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 44:5657-5660.
39. Sommerfelt, M. A., and B. Åsjö. 1995. Intercellular adhesion molecule 3, a candidate human immunodeficiency virus type 1 co-receptor on lymphoid and monocytoid cells. J. Gen. Virol. 76:1345-1352.
40. Spear, G. T., N. S. Lurain, C. J. Parker, M. Ghassemi, G. H. Payne, and M. Saifuddin. 1995. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated envelope viruses. J. Immunol. 155:4376-4381.
41. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425-434.
42. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
43. Stevenson, M., X. Zhang, and D. J. Volsky. 1987. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J. Virol. 61:3741-3748.
44. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
45. Tedder, T. F., D. A. Steeber, A. Chen, and P. Engel. 1995. The selectins: vascular adhesion molecules. FASEB J. 9:866-873.
46. Thali, M., A. Bukovsky, E. Kondo, B. Rosenwirth, C. T. Walsh, J. Sodroski, and H. G. Göttlinger. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363-365.
47. Wain-Hobson, S. 1992. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr. Top. Microbiol. Immunol. 176:181-193.
48. Wrightham, M., A. Schimpf, T. H. Pennington, F. Walker, and H. F. Sewell. 1991. HIV induces modulation of functionally important cellular antigens. J. Exp. Immunol. 85:75-79.
49. Zolla-Pazner, S., and S. Sharpe. 1995. A resting cell assay for improved detection of antibody-mediated neutralization of HIV-1 primary isolates. AIDS Res. Hum. Retroviruses 11:1449-1458.